SHARPS TECHNOLOGY INC C/WTS (TO PUR COM)(STSSW.US)

Company Encyclopedia

SHARPS TECHNOLOGY INC C/WTS (TO PUR COM)

STSSW.US

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

Innovations in Dermatology Trials: Embracing Digital Tools and Decentralized Approaches

The article discusses the shift towards decentralized and hybrid clinical trials in dermatology, highlighting the increasing use of digital tools. With over 16,000 dermatology trials listed, the integration of telemedicine, digital imaging, and wearables is transforming patient data collection. The share of studies using virtual elements has risen from 5% in 2017 to nearly 10% in 2025. These innovations aim to improve trial efficiency and patient engagement, addressing challenges like slow recruitment and variability in data collection. However, effective implementation remains a challenge, requiring careful planning and coordination among various stakeholders.

Pharmaceutical Technology·Yesterday at 01:15

09:40 ET Human Enhancement Technology Market to Reach USD 3.16 Billion by 2031, Growing at 17.4% CAGR - Valuates Reports

The global Human Enhancement Technology market is projected to grow from USD 1.045 billion in 2024 to USD 3.165 billion by 2031, at a CAGR of 17.4%. This growth is driven by the demand for improved physical, cognitive, and sensory capabilities across various sectors, including medical, industrial, and defense. Key factors include the need for enhanced performance in extreme environments, workplace safety improvements, and rehabilitation support. As acceptance of these technologies increases, they are seen as essential tools for productivity and quality of life enhancement.

prnewswire·01/19/2026 22:43

03:30 ET Digital Pathology Market Growing at 9.9% CAGR to 2031 as AI Adoption Accelerates, says a 2026 Mordor Intelligence Report

The digital pathology market is projected to grow at a CAGR of 9.90%, reaching over USD 3.2 billion by 2031, according to a Mordor Intelligence report. Key drivers include rising cancer rates, demand for faster diagnostics, and AI integration. North America leads the market due to advanced healthcare infrastructure, while Europe shows significant growth in routine diagnostics. Emerging trends include AI-powered tools for disease detection and remote pathology workflows. The market features established companies and new entrants focusing on innovation and strategic collaborations.

prnewswire·01/16/2026 16:32

-4.22%

prnewswire·01/16/2026 16:32

-4.22%

16:06 ET Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable

Jurek Kozyra, CEO of Nanovery, discusses on the Disruption Interruption podcast how DNA nanorobots and AI are revolutionizing molecular medicine. These innovations aim to reduce drug development times from 10-15 years to mere hours, potentially curing diseases by targeting mRNA. Kozyra highlights the inefficiencies of traditional medicine and the promise of nanorobots that can detect diseases in blood samples within 2-4 hours, significantly faster than conventional methods. This technology has shown promising results in clinical settings, marking a significant advancement in rapid diagnostics and drug discovery.

prnewswire·01/16/2026 05:07

prnewswire·01/16/2026 05:07

Barclays Research: Humanoid robotics industry expected to hit $200 billion market by 2035 due to advancements in AI tech.

Barclays Research has released a report predicting that the humanoid robotics industry will reach a $200 billion market by 2035, driven by advancements in AI technology. The report highlights the shift of humanoid robots from experimental to practical applications, particularly in manufacturing and healthcare. Significant improvements in AI reasoning, actuator technology, and battery systems have resulted in a 30-fold decrease in production costs over the past decade, facilitating this industry transformation.

Unusual Whales·01/15/2026 00:24